期刊文献+

临床药师参与1例药物相互作用致低血糖实践 被引量:1

Clinical Pharmacist Participating in the Practice of Drug Interaction Resulting in Hypoglycemia in 1 Case
下载PDF
导出
摘要 目的探讨临床药师在干预潜在药物相互作用中的作用。方法临床药师参与1例2型糖尿病并冠状动脉粥样硬化性心脏病突发低血糖的治疗过程,通过对治疗方案的评价,分析患者突发低血糖为硫酸氢氯吡格雷片与瑞格列奈片的相互作用所致,提出用药建议。结果医师采纳临床药师建议,调整药物治疗方案后未再出现低血糖反应。结论联合用药在临床药物治疗过程中普遍存在,临床药师应熟悉药物间可能存在的药物相互作用,从而减少或避免药品不良反应发生,保证患者的用药安全、有效。 Objective To investigate the role of clinical pharmacists in interfering with potential drug interactions.Methods Clinical pharmacist participated in the treatment of acute hypoglycemia in 1 patient with coronary atherosclerotic heart disease and type 2 diabetes mellitus.Through the evaluation of the whole treatment program,the author analyzed that the reason of the sudden hypoglycemia in patients was caused by the interaction between clopidogrel bisulfate tablet and regrainide tablet,and proposed the next treatment measures based on the comprehensive consideration of the patients’basic diseases.Results The physician followed the advice of the clinical pharmacist and hypoglycemia did not recur after the adjustment of medication regimen.Conclusion Combination drug use is common in clinical drug treatment.Clinical pharmacists should be familiar with the possible drug interactions between drugs,so as to reduce or avoid the occurrence of adverse reactions and ensure the safety and efficacy of drug use.
作者 刘芝 陈斌 董丽娥 LIU Zhi;CHEN Bin;DONG Li'e(Deprtment of Pharmacy,Mianzhu People's Hospital,Deyang,Sichuan,China 618200;Department of Pharmacy,Chinese People's Liberation Army Western Theater General Hospital,Chengdu,Sichuan,China 610036)
出处 《中国药业》 CAS 2020年第20期46-48,共3页 China Pharmaceuticals
关键词 瑞格列奈 氯吡格雷 临床药师 药物相互作用 药品不良反应 低血糖反应 repaglinide clopidogrel clinical pharmacist drug interaction adverse drug reaction hypoglycemia
  • 相关文献

参考文献5

二级参考文献51

  • 1杨延宗,黄从新,高连君,刘少稳,杨东辉,林治湖.阵发性心房颤动大静脉电隔离后肌袖内自发电活动的特点[J].中华心律失常学杂志,2004,8(3):146-150. 被引量:20
  • 2LIUJie,HUANGCong-xin,BAOMing-wei,WANGTeng.Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro[J].Chinese Medical Journal,2005(14):1210-1213. 被引量:12
  • 3龙德勇,刘兴鹏,马长生,董建增,赵文度,方冬平.心房颤动射频消融术中应用丙泊酚深度镇静的临床观察[J].中华心律失常学杂志,2006,10(5):338-341. 被引量:14
  • 4Lai XS, Yang LP, Li XT, et al. Human CYP2C8 : structure, sub- strate specificity, inhibitor selectivity, inducers and polymorphisms [J]. Curr Drug Metab, 2009; 10:1009 - 1047.
  • 5Klose TS, Blaisdell JA and Goldstein JA. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs [ J ]. Biochem Mol Toxicol, 1999 ; 13:289 - 295.
  • 6Nebot N, Crettol S, d'Esposito F, et al. Participation of CYP2C8 and CYP3A4 in the N - demethylation of imatinib in human hepatic microsomes [J]. Br J Pharmacol, 2010; 161:1059 - 1069.
  • 7Glowka F, Karainiewicz - Lada M, Grzeskowiak E, et al. Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis [ J ]. Eur J Drug Metab Pharmacokinet, 2011 ; 36 : 167 - 173.
  • 8Dai D, Zeldin DC, Blaisdell JA, et al. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [ J ]. Pharmacogenetics, 2001 ; 11:597 - 607.
  • 9Kudzi W, Dodoo ANO, Mills JJ. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population [J]. BMC Med Genet, 2009; 10:124.
  • 10Pechandova K, Buzkova H, Matouskova O, et al. Genetic Polymor- phisms of CYP2C8 in the Czech Republic [J]. Genet Test Mol Bio- markers, 2012 ;16:812 - 816.

共引文献1532

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部